Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 14, Issue 12, 2007, Pages 875-882

  Taliani, G ^a   Rucci, P ^b   Biliotti, E ^a   Cirrincione, L ^c   Aghemo, A ^d   Alberti, A ^e   Almasio, P L ^f   Bartolozzi, D ^g   Caporaso, N ^h   Coppola, R ⁱ   Chiaramonte, M ^j   Floreani, A ^e   Gaeta, G B ^k   Persico, M ^h   Secchi, G ^l   Versace, I ^a   Zacharia, S ^a   Mele, A ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

^g Clinic of Infectious Diseases Careggi   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ UNIVERSITY OF CAGLIARI   (Italy)

^j Department of General Medicine and Public Health ^*  (Italy)

^k SECOND UNIVERSITY OF NAPLES   (Italy)

^l Ist Naz Stud e la Cura dei Tumori   (Italy)

more..

Author keywords

Liver specific quality of life; Nonresponse to treatment; Physical comorbidity; Quality of life

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE QUESTIONNAIRE; COMORBIDITY; DEMOGRAPHY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFORMATION PROCESSING; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELAPSE; SELF REPORT; SHORT FORM 36; TREATMENT RESPONSE; VIREMIA; WORLD HEALTH ORGANIZATION QUALITY OF LIFE ASSESSMENT;

ADULT; AGED; COMORBIDITY; FEMALE; HEALTH STATUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LINEAR MODELS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 36749096877     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00883.x     Document Type: Article

References (22)

1. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998 27 : 209 212.
2. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999 30 : 1299 1301.
3. Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwall F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 2005 41 : 790 800.
4. Rowan PJ, Al-Jurdi R, Tavakoli-Tabasi S, Kunik ME, Satrom SL, EL-Serag HB. Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. J Clin Gastroenterol 2005 39 : 731 736.
5. Ware JE, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response The Interventional Therapy Group. Hepatology 1999 30 : 550 555.
6. Bonkovsky HL, Woolley JM the Consensus Interferon Study Group. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999 29 : 264 270.
7. McHutchison JG, Ware JE Jr., Bayliss MS et al. Hepatitis Interventional Therapy Group. The effects of Interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 2001 34 : 140 147.
8. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998 51 : 1025 1036.
9. De Girolamo G, Rucci P, Scocco P et al. Quality of life assessment: Validation of the Italian version of the WHOQOL-BRIEF. Epidemiol Psichiatr Soc 2000 9 : 45 55.
10. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease-specific questionnaire to measure heath-related quality of life in patients with chronic liver disease. Gut 1999 45 : 295 300.
11. Rucci P, Taliani G, Cirrincione L et al. Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis 2005 37 : 850 860. Epub 2005 Oct 10.
12. Dupont WD, Plummer WD Jr. Power and sample size calculations: a review and computer program. Control Clin Trials 1990 11 : 116 128.
13. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001 358 : 38 39.
14. Kramer L, Bauer E, Funk G et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002 37 : 349 354.
15. Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002 35 : 704 708.
16. Hassanein T, Cooksley G, Sulkowski M et al. The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. J Hepatol 2004 40 : 675 681.
17. Mathew A, Peiffer LP, Rhoades K, McGarrity TJ. Improvement in quality of life measures in patients with refractory hepatitis C, responding to retreatment with Pegylated interferon alpha-2b and ribavirin. Health Qual Life Outcomes 2006 4 : 30 Epub12 2006 May 12).
18. Jacobson IM, Gonzalez SA, Ahmed F et al. A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C. Am J Gastroenterol 2005 100 : 2453 2462.
19. Cammà C, Licata A, Cabibbo G, Latteri F, Craxì A. Treatment of hepatitis C: critical appraisal of the evidence. Expert Opin Pharmacother 2005 6 : 399 408.
20. Forton DM, Taylor-Robinson SD, Thomas HC. Cerebral dysfunction in chronic hepatitis C infection. J Viral Hepat 2003 10 : 81 86.
21. Waldron I. Sex differences in illness incidence, prognosis and mortality: issues and evidence. Soc Sci Med 1983 17 : 1107 1123.
22. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001 96 : 2737 2744.